RBR-9wt2wj进行中（未招募）未知
Squamous cell carcinoma of the skin with metastases to the parotid gland: factors predictions and survival in a single institution
Giulianno Molina de Melo0 个研究点开始时间: 2020年3月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 7Y 至 100Y（—）
入选标准
- •All patients with squamous cell carcinoma of the skin; with or without organ transplantation; submitted to surgical treatment in the mentioned period; with the obtaining of anatomopathological reports; clinical follow-up in the Database of surgeries performed in the Head and Neck Discipline
排除标准
- •All patients who lost follow-up; with minimum follow-up of three months; those with incomplete medical records; who were not operated on at the institution; who had distant metastases in the first presentation; who had no indication for surgery for other reasons; who had previous irradiation in the head area and neck; those which contained non-squamous cell carcinoma skin tumors
研究者
相似试验
进行中（未招募）
不适用
Skin cancer with spread to the parotid: evaluation of factors that worsen the clinical pictureRBR-36vxx7Giulianno Molina de Melo
已完成
不适用
Metastases of cutaneous squamous cell carcinoma in organ transplant recipients - The *SCOPE-ITSCC metastases study*10040900Skin cancersquamous cell carcinomaNL-OMON39568eids Universitair Medisch Centrum300
进行中（未招募）
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-DEEO Pharma A/S480
进行中（未招募）
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-FREO Pharma A/S480
进行中（未招募）
不适用
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-GBEO Pharma A/S480